Results 71 to 80 of about 103,266 (298)

Plasma metabolomics identifies signatures that distinguish heart failure with reduced and preserved ejection fraction

open access: yesESC Heart Failure, EarlyView.
Abstract Aims Two general phenotypes of heart failure (HF) are recognized: HF with reduced ejection fraction (HFrEF) and with preserved EF (HFpEF). To develop phenotype‐specific approaches to treatment, distinguishing biomarkers are needed. The goal of this study was to utilize quantitative metabolomics on a large, diverse population to replicate and ...
Fawaz Naeem   +13 more
wiley   +1 more source

Percutaneous mechanical circulatory support for acute right heart failure: A practical approach

open access: yesESC Heart Failure, EarlyView.
This is an overview of percutaneous mechanical circulatory support options for acute right heart failure, illustrating key clinical scenarios, device types, and principles of tailored device selection based on haemodynamics and underlying pathology. Abstract Acute right heart failure (RHF) represents a critical entity with significant morbidity and ...
Mario Gramegna   +18 more
wiley   +1 more source

Interconnected pathways and emerging therapies in chronic kidney disease and heart failure: A comprehensive review

open access: yesESC Heart Failure, EarlyView.
Abstract Chronic kidney disease (CKD) and chronic heart failure (HF) frequently coexist and, when comorbid, are associated with poorer outcomes. These two diseases have common risk factors, such as diabetes, obesity and hypertension, and common pathophysiological connected mechanisms, including inflammation, endothelial dysfunction, neurohormonal ...
Johann Bauersachs   +2 more
wiley   +1 more source

Effects of empagliflozin on uric acid levels during acute heart failure recompensation: A sub‐analysis of the EMPAG‐HF trial (Effects of Empagliflozin on Diuresis and Renal Function in Patients with Acute Decompensated Heart Failure)

open access: yesEuropean Journal of Heart Failure, EarlyView.
Effects of empagliflozin on uric acid levels during acute heart failure recompensation. Abstract Background Sodium–glucose cotransporter 2 inhibitors improve prognosis in chronic heart failure as part of currently recommended therapeutic strategies.
Jurgen Bogoviku   +7 more
wiley   +1 more source

Immune dysregulation as a key driver of peripartum cardiomyopathy – an exploratory advanced imaging and biomarker study

open access: yesEuropean Journal of Heart Failure, EarlyView.
Physiological postpartum remodelling and the pathological processes involved in peripartum cardiomyopathy (PPCM). 18FDG‐PET‐CT, 18F‐fluorodeoxyglucose positron emission tomography‐computed tomography; CCL3, chemokine (C‐C motif) ligand 3; CMR, cardiovascular magnetic resonance; CRP, C‐reactive protein; CSF‐1, colony‐stimulating factor 1; CXCL10 ...
Julian Hoevelmann   +14 more
wiley   +1 more source

Reversible cerebral vasoconstriction syndrome associated with a traditional Japanese training method under a waterfall named Takigyo: a case report

open access: yesAcute Medicine & Surgery, 2019
Case Takigyo is a traditional Japanese training method for psychosomatic conditions in which individuals meditate under a waterfall. A 55‐year‐old man presented with a mild headache and visual loss that occurred following Takigyo. On the day of admission,
Kiyoshi Takemoto, Nobuyuki Takahashi
doaj   +1 more source

Improving Activity of ACE Inhibitory Peptide by Sequence‐Based Rational Design: Properties, Function on Endothelial Cells, and Potential Antihypertensive Mechanism

open access: yesFood Frontiers, EarlyView.
The process diagram of this study develops the ACE inhibitory peptide by sequence‐based design and investigates its properties, functions on endothelial cells, and potential antihypertensive action mechanism. ABSTRACT The comprehension of the relationship between structure and function and mechanisms of intermolecular interactions within amino acid ...
Qingping Liang   +7 more
wiley   +1 more source

Home - About - Disclaimer - Privacy